Search Results 191-200 of 28522 for Crohns disease
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease ... and stage of disease, and previous ...
The goal of the study is to help researchers at Mayo Clinic better understand the causes of inflammatory bowel disease (IBD) and other gastrointestinal ...
Epidemiology of inflammatory bowel disease (Crohn's disease and ulcerative colitis); Natural history of inflammatory bowel disease; Diagnosis and disease ...
Transforming Healthcare and Outcomes for Children with Inflammatory Bowel Disease ... Participant eligibility includes age, gender, type and stage of disease, and ...
Inflammatory Bowel Disease Clinic. Patients with Inflammatory Bowel Disease (IBD) need a team of specialists working together to provide them with the best care ...
... Crohn's disease (CD). Also to assess the safety, immunogenicity and efficacy ... Participant eligibility includes age, gender, type and stage of disease, and ...
The blood and urine samples and quality of life data will be used for future research of IBD at Mayo Clinic and future research at Mayo Clinic to learn about, ...
The purpose of this study is to evaluate the long-term safety of a single dose of darvadstrocel in participants with Crohn's disease (CD) and complex perianal ...
The purpose of this study is to explore the effect of oral ozanimod as an induction treatment for subjects with moderately to severely active Crohn's Disease.
... Crohn's Disease. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can go twice as far to fight cancer.